You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

April 8, 2020

Laos Issues COVID-19 Regulations for Freight, Insurance, Mineral Processing, Hydropower, and Healthcare Industries

Subscribe to Updates

Cross-Border Transportation of Goods

The National Taskforce Committee for COVID-19 Prevention and Control has issued Guideline No. 020, Regarding Prime Minister’s Order No.02/PM, dated April 2, 2020, which includes directives aimed at the freight sector. The transportation of goods is one of the few operations that is still permitted to cross the Lao border, although this is subject to the following regulations:

  • The importation of goods by vehicles is authorized up to the loading point closest to the port of entry. Once the goods have been unloaded, the vehicle must depart immediately. Before entering Laos the driver must fill out a health form and undergo an examination, as recommended by the National Taskforce Committee for COVID-19 Prevention and Control.
  • For the transportation of goods that transit through Laos before being exported to a third country, vehicles can proceed to the loading point in Laos and onward to their destination. If it is necessary to use a vehicle from the country of origin to reach the destination, the vehicle must be sprayed with a disinfectant in accordance with the specified rules. Foreign drivers are also prohibited, so the driver must be a Lao national.

Insurance Operations

On March 31, 2020, the Department of State Enterprise Investment Management and Insurance, which is under the Ministry of Finance, issued Notification No. 0338, which provides the following measures:

  • Deferment of the deadline for submission of insurance company financial reports and other reporting duties relating to the operation of insurance businesses for the year 2019. The new submission deadline is April 30, 2020.
  • Requirement for life insurance and health insurance policies that have already been sold to also cover COVID-19-related symptoms, in accordance with the amount and duration of coverage agreed upon in the contract.
  • Requirement for all insurance companies to devise a plan to form teams of employees to work in their offices from April 1 to April 19, 2020, and to support other employees to work remotely. Alternatively, companies can devise a specific schedule for each employee to come to work on an alternating basis, in order to prevent the spread of the COVID-19. Insurance companies are also requested to ensure they can receive claims while the COVID-19 outbreak measures are in place.

Factories that Process Minerals and Hydropower Plants under Construction

On April 5, 2020, the Ministry of Mines and Energy issued Notification 0432/MEM, which orders hydropower plant construction projects and factories involved in exploration for and processing of minerals to suspend their activities from April 1 to April 19.

Until April 19, these operations are required to proceed as follows:

  • Manage their staff and personnel who are currently renting and staying in accommodation within the factory, and follow measures issued by the government. Employees and personnel should not leave the factory premises, or their accommodations, if it is not necessary (a phrase that is not yet defined). Employees and personnel must be prohibited from traveling to local places where there is a risk of contracting the virus.
  • Disseminate information about COVID-19 to employees and personnel on-site in order to prevent and combat the spread of the virus, in accordance with recommendations issued by the local authorities. Any employee who displays symptoms of the virus should be separated from the other employees, and the supervisor should immediately contact the emergency number (166 or 020-5406-6777) in order to implement the recommendations issued by the National Task Force.
  • Ensure that social distancing of two meters is strictly observed by all employees, provide masks, and ensure that soap is available for washing hands, or disinfectant is provided to kill the virus, in accordance with the recommendations of the National Task Force.
  • Disinfect the premises, including production sites, canteens, and accommodations, along with other areas where there is a risk of the virus spreading.

Facilities that have been closed and adversely impacted by COVID-19 should report the impact to the Ministry of Energy and Mines, and the related authorities, as indicated in Prime Minister’s Order No. 06/PM, dated March 29, 2020. In addition, the ministry welcomes comments regarding this notification from stakeholders and from the public and private sectors.

Private Hospitals and Clinics Prohibited from Treating COVID-19

Out of a concern about some private caregiving facilities in the country being inadequately equipped to handle the epidemic, on April 2, 2020, the Ministry of Health issued Notification 0413/MOH, ordering private hospitals and treatment facilities not to attempt treatment of COVID-19 patients (with limited exceptions for international-standard private hospitals). 

This notification followed the issuance of previous measures seemingly announcing the closure of private hospitals and private treatment centers. Together, however, these regulations mean that  specialized clinics and private hospitals can provide their usual medical services, but they are not allowed to attempt treatment of COVID-19 patients; if a case of COVID-19 is suspected, they should call the emergency hotline immediately.

For more details on these measures, or on any aspect of Laos’ response to the COVID-19 pandemic, please contact Dino Santaniello at [email protected].

Related Professionals

Industries

Aviation

Energy

Insurance

Life Sciences

Practices

Corporate/M&A

Regulatory Affairs

Location

RELATED INSIGHTS​ 

September 7, 2026
Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability. The decision took effect immediately upon its pronouncement at the court’s plenary session on August 28, 2026. Background The petition challenged the removal of article 4(f) from Law No. 13 of 2016 concerning Patents (Patent Law), as amended by Law No. 65 of 2024. Article 4(f) had excluded from patentability certain inventions relating to new uses of known substances. The petitioners argued that removing this provision would open the door to patent protection for second medical use inventions and facilitate patent evergreening—practices that can extend exclusivity periods, delay generic market entry, and reduce public access to affordable medicines. The petitioners included several patient advocacy and public-interest organizations: the Indonesian Dialysis Patients Community Association, the Indonesian Association of Drug Abuse Victims (PKNI), the Indonesian Pulmonary Hypertension Foundation (YHPI), the Rekat Peduli Indonesia Foundation, and the Indonesian Positive Women’s Association (IPPI), along with the Indonesia for Global Justice Association and four individual petitioners. The petitioners also challenged the constitutionality of the phrase “interested party” in article 70(1) of the Patent Law, arguing that it should be construed expressly to clarify who has standing to appeal a decision to grant a patent before the Board of Patent Appeal, and to allow a broader range of parties—such as patent holders, licensees, consumer organizations, prosecutors, aggrieved third parties, and others who may suffer direct or indirect harm from the grant of a patent—to
Read More
September 4, 2026
Blind boxes and collectibles have become increasingly popular, driven by the excitement of not knowing which character or design will be revealed until the package is opened. While most visible in the art toy market, the same concept is also used in the food industry. Confectionery, snacks, and other food products are sometimes sold with toys, character figures, cards, or other collectibles. A package might, for example, contain one of ten possible characters, with consumers knowing that an item is included but not which one they will receive. Some collections may also feature rare or “secret” items. For food businesses, however, adding a randomized toy or collectible involves more than a marketing decision. The food, the nonfood item, and the randomized mechanism may each raise different regulatory considerations in Thailand. Thai FDA Requirements for Nonfood Objects Packaged with Food The main food regulatory consideration is Ministry of Public Health Notification No. 310 B.E. 2551 (2008), which regulates food packaged together with things or objects that are not food. Under Notification No. 310, certain nonfood objects may be packaged together with food where they fall within specified exceptions, including objects that serve the following purposes: Maintaining the quality or standard of the food, such as a desiccant or oxygen absorber; Serving as a seasoning or as part of food preparation, such as chili powder sachets or seasoning sachets contained in instant noodle packages; or Functioning as an eating or food-preparation utensil, such as a spoon or fork included with instant noodles. Other nonfood objects that do not fall within these categories generally should not be placed inside the food container together with the food. Where a toy, collectible, or other nonfood object is intended to be sold together with a food product, businesses should therefore carefully consider the nature of
Read More
August 20, 2026
As part of its membership in Lex Mundi, Tilleke & Gibbins has released the latest edition of its Guide to Doing Business in Thailand, providing an overview of the legal, regulatory, and commercial considerations for companies establishing or expanding operations in Thailand. The 2026 edition offers practical insight into the country’s business environment, investment framework, and operational requirements. The guide covers a wide range of topics relevant to foreign and domestic investors, including: Investment incentives and promotion schemes Financial facilities and banking regulations Exchange controls and money transfers Import and export regulations Business structures and incorporation options Requirements for establishing a business Operational and compliance considerations Business cessation and insolvency procedures Employment and labor laws Taxation Immigration and visa requirements Prepared by Tilleke & Gibbins lawyers across multiple practice areas, the publication outlines key aspects of doing business in Thailand, including foreign investment restrictions, regulatory compliance obligations, corporate structures, employment requirements, and recent legal and economic developments affecting investors. The publication forms part of Lex Mundi’s Country Guides series, a global collection of jurisdiction-specific reference materials prepared by member firms around the world. Together, these guides help companies evaluate opportunities, compare regulatory environments, and plan international business activities across multiple markets. The full Guide to Doing Business in Thailand 2026 is available through the button below.
Read More
August 14, 2026
Thailand’s Office of the Insurance Commission (OIC) has issued guidelines clarifying the boundaries between permissible and prohibited activities for unlicensed individuals—including influencers, bloggers, and content creators—when communicating about insurance products on social media. The Good Practice Guidelines for Persons Not Licensed as Insurance Agents or Brokers Regarding the Dissemination of Insurance Content Through Digital Media B.E. 2569 (2026) took effect on July 24, 2026. Activities Requiring a License The guidelines reserve the following activities for licensed agents and brokers: Soliciting or facilitating insurance contracts. Providing personalized advice on product suitability. Recommending policy cancellation to purchase promoted products. Creating links that facilitate contract formation. Receiving performance-based compensation tied to policies or premiums generated. Importantly, boilerplate disclaimers such as “this is not a recommendation to buy insurance” will not shield individuals from liability if the OIC views the content as personalized advice or solicitation. Permitted Activities Unlicensed persons may present general educational content about insurance—such as explaining terminology, sharing industry statistics, reporting news, or sharing personal experiences—provided the content does not target specific individuals to purchase from specific companies. The guidelines also set out best practices for communication, including presenting information in a fair and balanced manner that covers both benefits and limitations, encouraging consumers to read policy terms and consult licensed professionals, verifying information from credible sources before dissemination, and exercising special care when the audience may include vulnerable groups such as persons aged 60 and older. Prohibited Practices Prohibited practices include fear-based marketing, creating artificial urgency, omitting material limitations, making exaggerated claims, falsely claiming professional credentials, using fake engagement mechanisms, and sharing false or misleading content. The guidelines also reinforce the prohibitions under section 83 of the Life Insurance Act B.E. 2535 and section 78 of the Non-Life Insurance Act B.E. 2535 against soliciting insurance contracts with foreign operators
Read More